US Biomax, Inc.

SKT961

Skin cancer and normal tissue array, 48 cases/96 cores

Microarray Panel:Skin carcinoma tissue microarray, including 48 cases of normal, benign and cancerous tissues of the skin and suBCutaneous tissues in duplicates
Cores:96
Cases:48
Layout:12 cols × 8 rows
Core Diameter:1.5 mm
Thickness:4 µm
Quality Control:H&E, IHC anti-Cytokeratin
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.


Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
123456789101112
A Pen Ski Ski Hea Vul Pen Ski Ski Sub Sub Sca Sub
B Pen Ski Ski Hea Vul Pen Ski Ski Sub Sub Sca Sub
C Pen Ski Pen Pen Ski Ski Pen Ski Ski Pen Pen Pen
D Pen Ski Pen Pen Ski Ski Pen Ski Ski Pen Pen Pen
E Pen Ski Ski Ski Ski Vul Ski Ski Ski Ski Ski Sca
F Pen Ski Ski Ski Ski Vul Ski Ski Ski Ski Ski Sca
G Lym Ski Ski Sca Fac Che Sca Ski Tru Ski Vul Che
H Lym Ski Ski Sca Fac Che Sca Ski Tru Ski Vul Che
Legend: Che - Chest wall, dermis, subcutaneous tissue, Fac - Face, subcutaneous tissue, Hea - Head and neck, ear, Lym - Lymph node, inguinal, Pen - Penis, Sca - Scalp, subcutaneous tissue, Ski - Skin, neck, dermis, subcutaneous tissue, Sub - Subcutaneous tissue, Tru - Trunk, subcutaneous tissue, Vul - Vulva, subcutaneous tissue

- Benign tumor, - , - Malignant tumor, - Metastasis, - , - Normal tissue

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Grade TNM Type †
A1 1 M 53 Penis Normal skin Norma
A2 2 F 15 Skin, leg Normal skin Normal
A3 3 M 57 Skin, wrist Chronic ulcer Inflammatory
A4 4 M 1 Head and neck, ear Skin polyp Benign
A5 5 F 20 Vulva Condyloma acuminata (HPV+) Benign
A6 6 M 17 Penis Condyloma acuminata acuminatum Benign
A7 7 M 25 Skin Granuloma Inflammatory
A8 8 M 10/12 Skin Hemangioma Benign
A9 9 M 22 Subcutaneous tissue Neurofibroma Benign
A10 10 F 44 Subcutaneous tissue Neurofibroma Benign
A11 11 F 24 Scalp, subcutaneous tissue Neurofibroma Benign
A12 12 F 67 Subcutaneous tissue Fibroma Benign
B1 13 M 53 Penis Normal skin Norma
B2 14 F 15 Skin, leg Normal skin Normal
B3 15 M 57 Skin, wrist Chronic ulcer Inflammatory
B4 16 M 1 Head and neck, ear Skin polyp Benign
B5 17 F 20 Vulva Condyloma acuminata (HPV+) Benign
B6 18 M 17 Penis Condyloma acuminata acuminatum Benign
B7 19 M 25 Skin Granuloma Inflammatory
B8 20 M 10/12 Skin Hemangioma Benign
B9 21 M 22 Subcutaneous tissue Neurofibroma Benign
B10 22 F 44 Subcutaneous tissue Neurofibroma Benign
B11 23 F 24 Scalp, subcutaneous tissue Neurofibroma Benign
B12 24 F 67 Subcutaneous tissue Fibroma Benign
C1 25 M 50 Penis Squamous cell carcinoma I T1N0M0 Malignant
C2 26 M 59 Skin, face Squamous cell carcinoma I T1N0M0 Malignant
C3 27 M 67 Penis Squamous cell carcinoma I T1N0M0 Malignant
C4 28 M 40 Penis Squamous cell carcinoma I T1N0M0 Malignant
C5 29 F 62 Skin Squamous cell carcinoma I T1N0M0 Malignant
C6 30 F 50 Skin, leg Squamous cell carcinoma I T2N0M0 Malignant
C7 31 M 34 Penis Squamous cell carcinoma I T1N0M0 Malignant
C8 32 M 79 Skin Squamous cell carcinoma I T2N0M0 Malignant
C9 33 F 53 Skin, head Squamous cell carcinoma I T1N0M0 Malignant
C10 34 M 47 Penis Squamous cell carcinoma I T1N1M0 Malignant
C11 35 M 40 Penis Squamous cell carcinoma I T1N0M0 Malignant
C12 36 M 71 Penis Squamous cell carcinoma I T1N0M0 Malignant
D1 37 M 50 Penis Squamous cell carcinoma I T1N0M0 Malignant
D2 38 M 59 Skin, face Squamous cell carcinoma I T1N0M0 Malignant
D3 39 M 67 Penis Squamous cell carcinoma I T1N0M0 Malignant
D4 40 M 40 Penis Squamous cell carcinoma I T1N0M0 Malignant
D5 41 F 62 Skin Squamous cell carcinoma I T1N0M0 Malignant
D6 42 F 50 Skin, leg Squamous cell carcinoma I T2N0M0 Malignant
D7 43 M 34 Penis Squamous cell carcinoma I T1N0M0 Malignant
D8 44 M 79 Skin Squamous cell carcinoma I T2N0M0 Malignant
D9 45 F 53 Skin, head Squamous cell carcinoma I T1N0M0 Malignant
D10 46 M 47 Penis Squamous cell carcinoma I T1N1M0 Malignant
D11 47 M 40 Penis Squamous cell carcinoma I T1N0M0 Malignant
D12 48 M 71 Penis Squamous cell carcinoma I T1N0M0 Malignant
E1 49 M 57 Penis Squamous cell carcinoma I T1N0M0 Malignant
E2 50 M 61 Skin, head Squamous cell carcinoma II T1N0M0 Malignant
E3 51 M 78 Skin, face Squamous cell carcinoma II T1N0M0 Malignant
E4 52 M 53 Skin, trunk Squamous cell carcinoma II T1N0M0 Malignant
E5 53 M 67 Skin, trunk Squamous cell carcinoma II T2N0M0 Malignant
E6 54 F 65 Vulva Squamous cell carcinoma II T1N0M0 Malignant
E7 55 M 36 Skin, head Squamous cell carcinoma II T1N0M0 Malignant
E8 56 M 72 Skin, head Squamous cell carcinoma III T2N0M0 Malignant
E9 57 M 62 Skin, leg Basal cell carcinoma T1N0M0 Malignant
E10 58 M 89 Skin, face Basal cell carcinoma T1N0M0 Malignant
E11 59 M 80 Skin, face Basal cell carcinoma T1N0M0 Malignant
E12 60 F 35 Scalp, subcutaneous tissue Neuroendocrine carcinoma T2N0M0 Malignant
F1 61 M 57 Penis Squamous cell carcinoma I T1N0M0 Malignant
F2 62 M 61 Skin, head Squamous cell carcinoma II T1N0M0 Malignant
F3 63 M 78 Skin, face Squamous cell carcinoma II T1N0M0 Malignant
F4 64 M 53 Skin, trunk Squamous cell carcinoma II T1N0M0 Malignant
F5 65 M 67 Skin, trunk Squamous cell carcinoma II T2N0M0 Malignant
F6 66 F 65 Vulva Squamous cell carcinoma II T1N0M0 Malignant
F7 67 M 36 Skin, head Squamous cell carcinoma II T1N0M0 Malignant
F8 68 M 72 Skin, head Squamous cell carcinoma III T2N0M0 Malignant
F9 69 M 62 Skin, leg Basal cell carcinoma T1N0M0 Malignant
F10 70 M 89 Skin, face Basal cell carcinoma T1N0M0 Malignant
F11 71 M 80 Skin, face Basal cell carcinoma T1N0M0 Malignant
F12 72 F 35 Scalp, subcutaneous tissue Neuroendocrine carcinoma T2N0M0 Malignant
G1 73 M 62 Lymph node, inguinal Metastatic melanoma Metastasis
G2 74 M 60 Skin, chest Melanoma Malignant
G3 75 M 60 Skin, foot Melanoma Malignant
G4 76 F 64 Scalp, subcutaneous tissue Plasmacytoma Malignant
G5 77 F 53 Face, subcutaneous tissue Fibrosarcoma? Malignant
G6 78 M 44 Chest wall, subcutaneous tissue Dermatofibrosarcoma protuberans Malignant
G7 79 M 45 Scalp, subcutaneous tissue Dermatofibrosarcoma protuberans Malignant
G8 80 F 64 Skin, leg, subcutaneous tissue Malignant fibrous histiocytoma Malignant
G9 81 F 41 Trunk, subcutaneous tissue Dermatofibrosarcoma protuberans Malignant
G10 82 F 41 Skin, neck, dermis, subcutaneous tissue Metastatic squamous cell carcinoma of unknown site Metastasis
G11 83 M 56 Vulva, subcutaneous tissue Metastatic adenocarcinoma Metastasis
G12 84 F 81 Chest wall, dermis, subcutaneous tissue Metastatic breast carcinoma Metastasis
H1 85 M 62 Lymph node, inguinal Metastatic melanoma Metastasis
H2 86 M 60 Skin, chest Melanoma Malignant
H3 87 M 60 Skin, foot Melanoma Malignant
H4 88 F 64 Scalp, subcutaneous tissue Plasmacytoma Malignant
H5 89 F 53 Face, subcutaneous tissue Fibrosarcoma? Malignant
H6 90 M 44 Chest wall, subcutaneous tissue Dermatofibrosarcoma protuberans Malignant
H7 91 M 45 Scalp, subcutaneous tissue Dermatofibrosarcoma protuberans Malignant
H8 92 F 64 Skin, leg, subcutaneous tissue Malignant fibrous histiocytoma Malignant
H9 93 F 41 Trunk, subcutaneous tissue Dermatofibrosarcoma protuberans Malignant
H10 94 F 41 Skin, neck, dermis, subcutaneous tissue Metastatic squamous cell carcinoma of unknown site Metastasis
H11 95 M 56 Vulva, subcutaneous tissue Metastatic adenocarcinoma Metastasis
H12 96 F 81 Chest wall, dermis, subcutaneous tissue Metastatic breast carcinoma Metastasis


† For precise diagnosis, refer to pathology description.

**The grade 1-3 (or I-III) in Pathology Diagnosis is equivalent to well-differentiated, moderately-differentiated or poorly differentiated, respectively, under microscope.
Grade 1 or well-differentiated: Cells appear normal and are not growing rapidly.
Grade 2 or moderately-differentiated: Cells appear slightly different than normal.
Grade 3 or poorly differentiated: Cells appear abnormal and tend to grow and spread more aggressively.
Grade 4 or undifferentiated: *(for certain tumors), features are not significantly distinguishing to make it look any different from undifferentiated cancers which occur in other organs.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Sorry, this tissue array cannot be compared to find overlapping cases.